OBI Pharma Inc (台灣浩鼎) yesterday said it is to give an oral presentation about its new breast cancer vaccine, OBI-822, at the annual meeting of the American Society of Clinical Oncology (ASCO) in June.
The company, which received a notice from ASCO late on Wednesday, said ASCO is among the world’s largest and most influential professional organizations representing physicians of all oncology specialties providing care for cancer patients.
With more than 40,000 members, the organization reviews about 5,800 submissions each year, and OBI Pharma’s OBI-822 is among only 3.8 percent of submissions that have been selected for an oral presentation this year, the company said.
However, OBI Pharma chairman Michael Chang (張念慈) said that ASCO’s selection has little commercial implication for the company’s new treatment.
“ASCO’s selection is by no means an endorsement for the new drug, and will not affect the progress of ongoing clinical trials and regulatory approval, apart from a much-needed boost to morale among our employees,” Chang said at a press conference.
OBI Pharma has been embroiled in controversy since Feb. 21, when it announced that the results of its second and third-phase clinical trials of OBI-822 showed “no statistical significance.”
Since then, OBI Pharma shares have plummeted by nearly 40 percent from this year’s high of NT$719 on Feb. 19 to NT$351 at the end of Wednesday’s session.
The shares were suspended for trading on the Taipei Exchange to conform with regulatory guidelines at a time of disclosing material information.
Academia Sinica President Wong Chi-huey (翁啟惠), a close collaborator with the company, has also come under fire since it was revealed that his daughter, Wong Yu-shioh (翁郁秀), had sold a portion of her holdings in OBI Pharma on Feb. 18, just before prices went spiraling downward.
The Chinese-language Apple Daily yesterday reported that Wong Chi-huey had authorized the stock sale with his daughter’s stock broker at E.Sun Securities Co (玉山證券).
Regarding the allegations, Chang said that the company employs industry-standard protocols, where clinical trial information is handled and compartmentalized by external organizations.
“There were no instances of information leakage, and the allegations of insider trading using non-public information are unfounded,” Chang said, adding that Wong Chi-huey did not know of the discouraging clinical trial results until about two hours before the company held a press conference on Feb. 21.
However, Chang was unable to explain how Wong Chi-huey was able to authorize the stock sale on behalf of his daughter.
Wong Chi-huey had previously pledged that he did not hold any biotechnology stock positions.
“The company had instructed board members, managers and employees to halt all stock trades for one month prior to Feb. 21, but we had failed to include Wong Chi-huey and the company regrets the oversight,” Chang said.
The Ministry of Foreign Affairs (MOFA) yesterday said it is closely monitoring developments in Venezuela, and would continue to cooperate with democratic allies and work together for regional and global security, stability, and prosperity. The remarks came after the US on Saturday launched a series of airstrikes in Venezuela and kidnapped Venezuelan President Nicolas Maduro, who was later flown to New York along with his wife. The pair face US charges related to drug trafficking and alleged cooperation with gangs designated as terrorist organizations. Maduro has denied the allegations. The ministry said that it is closely monitoring the political and economic situation
UNRELENTING: China attempted cyberattacks on Taiwan’s critical infrastructure 2.63 million times per day last year, up from 1.23 million in 2023, the NSB said China’s cyberarmy has long engaged in cyberattacks against Taiwan’s critical infrastructure, employing diverse and evolving tactics, the National Security Bureau (NSB) said yesterday, adding that cyberattacks on critical energy infrastructure last year increased 10-fold compared with the previous year. The NSB yesterday released a report titled Analysis on China’s Cyber Threats to Taiwan’s Critical Infrastructure in 2025, outlining the number of cyberattacks, major tactics and hacker groups. Taiwan’s national intelligence community identified a large number of cybersecurity incidents last year, the bureau said in a statement. China’s cyberarmy last year launched an average of 2.63 million intrusion attempts per day targeting Taiwan’s critical
‘SLICING METHOD’: In the event of a blockade, the China Coast Guard would intercept Taiwanese ships while its navy would seek to deter foreign intervention China’s military drills around Taiwan this week signaled potential strategies to cut the nation off from energy supplies and foreign military assistance, a US think tank report said. The Chinese People’s Liberation Army (PLA) conducted what it called “Justice Mission 2025” exercises from Monday to Tuesday in five maritime zones and airspace around Taiwan, calling them a warning to “Taiwanese independence” forces. In a report released on Wednesday, the Institute for the Study of War said the exercises effectively simulated blocking shipping routes to major port cities, including Kaohsiung, Keelung and Hualien. Taiwan would be highly vulnerable under such a blockade, because it
UNDER WAY: The contract for advanced sensor systems would be fulfilled in Florida, and is expected to be completed by June 2031, the Pentagon said Lockheed Martin has been given a contract involving foreign military sales to Taiwan to meet what Washington calls “an urgent operational need” of Taiwan’s air force, the Pentagon said on Wednesday. The contract has a ceiling value of US$328.5 million, with US$157.3 million in foreign military sales funds obligated at the time of award, the Pentagon said in a statement. “This contract provides for the procurement and delivery of 55 Infrared Search and Track Legion Enhanced Sensor Pods, processors, pod containers and processor containers required to meet the urgent operational need of the Taiwan air force,” it said. The contract’s work would be
RSS